Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1968 1
1969 1
1970 1
1976 1
1977 3
1979 1
1981 1
1984 1
1986 2
1987 1
1988 1
1989 2
1992 2
1994 1
1995 2
1996 2
1998 1
1999 3
2000 2
2001 1
2002 1
2003 1
2004 2
2005 4
2006 3
2007 3
2008 6
2009 2
2010 5
2011 7
2012 8
2013 7
2014 14
2015 21
2016 17
2017 31
2018 31
2019 40
2020 32
2021 33
2022 37
2023 33
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

349 results

Results by year

Filters applied: . Clear all
Page 1
Polypill Strategy in Secondary Cardiovascular Prevention.
Castellano JM, Pocock SJ, Bhatt DL, Quesada AJ, Owen R, Fernandez-Ortiz A, Sanchez PL, Marin Ortuño F, Vazquez Rodriguez JM, Domingo-Fernández A, Lozano I, Roncaglioni MC, Baviera M, Foresta A, Ojeda-Fernandez L, Colivicchi F, Di Fusco SA, Doehner W, Meyer A, Schiele F, Ecarnot F, Linhart A, Lubanda JC, Barczi G, Merkely B, Ponikowski P, Kasprzak M, Fernandez Alvira JM, Andres V, Bueno H, Collier T, Van de Werf F, Perel P, Rodriguez-Manero M, Alonso Garcia A, Proietti M, Schoos MM, Simon T, Fernandez Ferro J, Lopez N, Beghi E, Bejot Y, Vivas D, Cordero A, Ibañez B, Fuster V; SECURE Investigators. Castellano JM, et al. N Engl J Med. 2022 Sep 15;387(11):967-977. doi: 10.1056/NEJMoa2208275. Epub 2022 Aug 26. N Engl J Med. 2022. PMID: 36018037 Clinical Trial.
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597. Global Spine J. 2023. PMID: 37222100 Free PMC article. No abstract available.
Post COVID-19 irritable bowel syndrome.
Marasco G, Cremon C, Barbaro MR, Cacciari G, Falangone F, Kagramanova A, Bordin D, Drug V, Miftode E, Fusaroli P, Mohamed SY, Ricci C, Bellini M, Rahman MM, Melcarne L, Santos J, Lobo B, Bor S, Yapali S, Akyol D, Sapmaz FP, Urun YY, Eskazan T, Celebi A, Kacmaz H, Ebik B, Binicier HC, Bugdayci MS, Yağcı MB, Pullukcu H, Kaya BY, Tureyen A, Hatemi İ, Koc ES, Sirin G, Calıskan AR, Bengi G, Alıs EE, Lukic S, Trajkovska M, Hod K, Dumitrascu D, Pietrangelo A, Corradini E, Simren M, Sjölund J, Tornkvist N, Ghoshal UC, Kolokolnikova O, Colecchia A, Serra J, Maconi G, De Giorgio R, Danese S, Portincasa P, Di Sabatino A, Maggio M, Philippou E, Lee YY, Salvi D, Venturi A, Borghi C, Zoli M, Gionchetti P, Viale P, Stanghellini V, Barbara G; GI-COVID19 study group. Marasco G, et al. Gut. 2022 Dec 9:gutjnl-2022-328483. doi: 10.1136/gutjnl-2022-328483. Online ahead of print. Gut. 2022. PMID: 36591612
Dual diagnosis: an European perspective.
Torrens M, Mestre-Pintó JI, Montanari L, Vicente J, Domingo-Salvany A. Torrens M, et al. Adicciones. 2017 Jan 1;29(1):3-5. doi: 10.20882/adicciones.933. Adicciones. 2017. PMID: 28170050 Free article. Review. English, Spanish.
The role of vitamin D in prevention OF COVID-19 and its severity: an umbrella review.
Margarucci LM, Montanari E, Gianfranceschi G, Caprara C, Valeriani F, Piccolella A, Lombardi V, Scaramucci E, Romano Spica V. Margarucci LM, et al. Acta Biomed. 2021 Oct 1;92(S6):e2021451. doi: 10.23750/abm.v92iS6.12216. Acta Biomed. 2021. PMID: 34739473 Free PMC article. Review.
BACKGROUND AND AIM: Vitamin D is known to modulate immune response and its deficiency was associated with respiratory distress in patients hospitalized for pneumonia. Nevertheless, numerous reviews on vitamin D in COVID-19 patients have shown conflicting results, as …
BACKGROUND AND AIM: Vitamin D is known to modulate immune response and its deficiency was associated with respiratory distress in pat …
Vitamin D status and COVID-19 prevention in a worker subgroup in Italy.
Ubaldi F, Montanari E, Margarucci LM, Caprara C, Gianfranceschi G, Scaramucci E, Piccolella A, Valeriani F, Romano Spica V. Ubaldi F, et al. Work. 2023;75(2):391-400. doi: 10.3233/WOR-220387. Work. 2023. PMID: 36641729
BACKGROUND: Low levels of vitamin D are widespread in the world's population and associated with sun exposure, genetics, and lifestyles. ...Vitamin D supplementation was performed between April and June 2021, on workers (n = 139) and showed 25(OH)D serum leve …
BACKGROUND: Low levels of vitamin D are widespread in the world's population and associated with sun exposure, genetics, and lifestyl …
Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity?
Cianni L, Feldmann CW, Gilberg E, Gütschow M, Juliano L, Leitão A, Bajorath J, Montanari CA. Cianni L, et al. J Med Chem. 2019 Dec 12;62(23):10497-10525. doi: 10.1021/acs.jmedchem.9b00683. Epub 2019 Aug 15. J Med Chem. 2019. PMID: 31361135 Review.
[Role of vitamin D in the pathogenesis of chronic kidney disease].
Cozzolino M, Brunini F, Capone V, Ricca F, Kwaidri Y, Montanari E, Cusi D. Cozzolino M, et al. Recenti Prog Med. 2013 Jan;104(1):33-40. doi: 10.1701/1226.13593. Recenti Prog Med. 2013. PMID: 23439539 Review. Italian.
These disorders, involving serum levels of calcium, phosphorus, parathyroid hormone, and vitamin D, have a striking impact on patient prognosis as they affect the cardiovascular system. ...These mechanisms explain, at least in part, vitamin D status influence in avo …
These disorders, involving serum levels of calcium, phosphorus, parathyroid hormone, and vitamin D, have a striking impact on patient …
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review.
Ferro M, Crocetto F, Barone B, Del Giudice F, Maggi M, Lucarelli G, Busetto GM, Autorino R, Marchioni M, Cantiello F, Crocerossa F, Luzzago S, Piccinelli M, Mistretta FA, Tozzi M, Schips L, Falagario UG, Veccia A, Vartolomei MD, Musi G, de Cobelli O, Montanari E, Tătaru OS. Ferro M, et al. Ther Adv Urol. 2023 Apr 17;15:17562872231164803. doi: 10.1177/17562872231164803. eCollection 2023 Jan-Dec. Ther Adv Urol. 2023. PMID: 37113657 Free PMC article. Review.
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
349 results